Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Monday, 21 September 2020, 21:10 HKT/SGT
Share:
    

Source: Trinity Limited
Trinity Entered into New Global Licensing Arrangements with Aquascutum

HONG KONG, Sept 21, 2020 - (ACN Newswire) - Trinity Limited ("Trinity" or the "Group", stock code: 891), a leading fashion retailer and owner of premium global brands, proudly announced the completion of licensing agreements with Aquascutum. Under the terms of the 3-year agreements with option to renew every 3 years at Trinity's discretion, Aquascutum has granted Trinity exclusive rights to design, manufacture and distribute its products in Greater China and appointed Trinity as its exclusive licensing agent to manage its global licensing business.

"Trinity is pleased to enter into a new global licensing arrangement with Aquascutum" said Sun Weiying, the Chief Executive Officer of Trinity. "Aquascutum is a luxurious heritage brand originated in Britain with a long history and a strong brand image globally. The Group sees good business potentials in developing products bearing the "Aquascutum" brand. Licensing the use of the "Aquascutum" trademarks in Greater China as well as acting as the brand's exclusive agent globally is a logical strategic move to expand the Group's brand portfolio and can help improve the Group's revenue and income."

About Trinity Limited (Stock Code: 891)
Trinity Limited, a publicly-listed company on the Stock Exchange of Hong Kong and a subsidiary of the privately held Beijing Ruyi Fashion Investment Holding Company Limited, is one of the leading retailers and owners of premium brands serving Greater China and Europe, as well as licensing its wholly-owned brands globally. The Group manages four international brands, namely Cerruti 1881, Gieves & Hawkes and Kent & Curwen, which are self-owned, and D'URBAN, which it operates under a long-term license in Greater China.
Media enquiries

Strategic Financial Relations Limited
Veron Ng +852 2864 4831 veron.ng@sprg.com.hk
Stephanie Liu +852 2864 4852 stephanie.liu@sprg.com.hk
Rachel Lau +852 2864 4824 rachel.lau@sprg.com.hk




Topic: Press release summary
Source: Trinity Limited

Sectors: Daily Finance, Daily News
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
Magnolia Welcomes Tech Pioneer Luc Haldimann as New Board Chairman to Expand Global Growth and AI Strategy  
Nov 28, 2025 00:00 HKT/SGT
NEC Launches Sales Support Solution Utilizing Agentic AI  
Thursday, November 27, 2025 9:31:00 PM
Fujitsu and Yamaguchi University develop low-power edge computing technology for near real-time image processing on small satellites  
Thursday, November 27, 2025 9:00:00 PM
Tat Hong Equipment Service Co., Ltd. Announces 2025/26 Interim Results  
Nov 27, 2025 18:43 HKT/SGT
PLN Collaborates with Norwegian and Japanese Stakeholders to Advance High-Integrity Cross-Border Carbon Markets at COP30  
Nov 27, 2025 18:30 HKT/SGT
Geespace Accelerates Global Expansion as GEESATCOM Enters New Markets  
Nov 27, 2025 15:30 HKT/SGT
KEF, the premium speaker brand of Gold Peak, partners with Huawei to unlock new wireless high-fidelity experience with HUAWEI HiPlay  
Nov 27, 2025 13:29 HKT/SGT
World's first ever spiral escalator renewal project conducted at a commercial facility in Mexico   
Thursday, November 27, 2025 10:00:00 AM
CBL International Limited Wins Prestigious 'CGMA Excellent Sustainability Award' at the CGMA Annual Awards 2025  
Nov 26, 2025 18:54 HKT/SGT
Eisai Completes Rolling Submission to US FDA for LEQEMBI(R) IQLIK(TM) (lecanemabirmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease Under Fast Track Status  
Wednesday, November 26, 2025 6:42:00 PM
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: